WO2010002059A1 - Method of preparing hematite platelet, hematite platelet prepared using the same, and hematite platelet pigment including the hematite platelet - Google Patents
Method of preparing hematite platelet, hematite platelet prepared using the same, and hematite platelet pigment including the hematite platelet Download PDFInfo
- Publication number
- WO2010002059A1 WO2010002059A1 PCT/KR2008/004561 KR2008004561W WO2010002059A1 WO 2010002059 A1 WO2010002059 A1 WO 2010002059A1 KR 2008004561 W KR2008004561 W KR 2008004561W WO 2010002059 A1 WO2010002059 A1 WO 2010002059A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hematite
- platelet
- particles
- prepared
- potassium
- Prior art date
Links
- 229910052595 hematite Inorganic materials 0.000 title claims abstract description 269
- 239000011019 hematite Substances 0.000 title claims abstract description 269
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 title claims abstract description 269
- 238000000034 method Methods 0.000 title claims abstract description 65
- 239000000049 pigment Substances 0.000 title claims abstract description 46
- 239000002245 particle Substances 0.000 claims abstract description 123
- 239000000243 solution Substances 0.000 claims abstract description 49
- 239000003513 alkali Substances 0.000 claims abstract description 45
- 150000003839 salts Chemical class 0.000 claims abstract description 38
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000000654 additive Substances 0.000 claims abstract description 34
- 230000000996 additive effect Effects 0.000 claims abstract description 34
- 239000002243 precursor Substances 0.000 claims abstract description 31
- 239000007864 aqueous solution Substances 0.000 claims abstract description 28
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 17
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 17
- 239000013067 intermediate product Substances 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002585 base Substances 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 30
- 239000011575 calcium Substances 0.000 claims description 23
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 19
- 229910000859 α-Fe Inorganic materials 0.000 claims description 16
- 229910052700 potassium Inorganic materials 0.000 claims description 13
- 229910052744 lithium Inorganic materials 0.000 claims description 12
- 239000002105 nanoparticle Substances 0.000 claims description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(III) nitrate Inorganic materials [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 claims description 7
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 6
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 6
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052681 coesite Inorganic materials 0.000 claims description 4
- 229910052906 cristobalite Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229960003975 potassium Drugs 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 229910052682 stishovite Inorganic materials 0.000 claims description 4
- 229910052905 tridymite Inorganic materials 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 229910006404 SnO 2 Inorganic materials 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 3
- 239000000920 calcium hydroxide Substances 0.000 claims description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 3
- 229910052593 corundum Inorganic materials 0.000 claims description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 239000011698 potassium fluoride Substances 0.000 claims description 3
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 3
- 235000011151 potassium sulphates Nutrition 0.000 claims description 3
- 229910001845 yogo sapphire Inorganic materials 0.000 claims description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- 229910000360 iron(III) sulfate Inorganic materials 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000011181 potassium carbonates Nutrition 0.000 claims 1
- 235000010333 potassium nitrate Nutrition 0.000 claims 1
- 239000004323 potassium nitrate Substances 0.000 claims 1
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 1
- 235000011009 potassium phosphates Nutrition 0.000 claims 1
- 239000011248 coating agent Substances 0.000 abstract description 9
- 238000000576 coating method Methods 0.000 abstract description 9
- 229910052751 metal Inorganic materials 0.000 abstract description 7
- 239000002184 metal Substances 0.000 abstract description 7
- 229910052742 iron Inorganic materials 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 description 35
- 239000011259 mixed solution Substances 0.000 description 18
- 239000010410 layer Substances 0.000 description 16
- 239000003086 colorant Substances 0.000 description 13
- 239000013078 crystal Substances 0.000 description 13
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 11
- 239000012467 final product Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 10
- 238000001878 scanning electron micrograph Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000001027 hydrothermal synthesis Methods 0.000 description 9
- 239000011247 coating layer Substances 0.000 description 8
- -1 for example Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229910010270 TiOCl2 Inorganic materials 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 235000019646 color tone Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000003973 paint Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 239000004606 Fillers/Extenders Substances 0.000 description 3
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 3
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 238000005245 sintering Methods 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 229910010415 TiO(OH) Inorganic materials 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910001566 austenite Inorganic materials 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940031098 ethanolamine Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010335 hydrothermal treatment Methods 0.000 description 2
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 2
- FLTRNWIFKITPIO-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe] FLTRNWIFKITPIO-UHFFFAOYSA-N 0.000 description 2
- 229910001510 metal chloride Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000011120 plywood Substances 0.000 description 2
- 229940094035 potassium bromide Drugs 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 229960004418 trolamine Drugs 0.000 description 2
- 229910018626 Al(OH) Inorganic materials 0.000 description 1
- 229910016874 Fe(NO3) Inorganic materials 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 229910010416 TiO(OH)2 Inorganic materials 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052598 goethite Inorganic materials 0.000 description 1
- AEIXRCIKZIZYPM-UHFFFAOYSA-M hydroxy(oxo)iron Chemical compound [O][Fe]O AEIXRCIKZIZYPM-UHFFFAOYSA-M 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- AJCDFVKYMIUXCR-UHFFFAOYSA-N oxobarium;oxo(oxoferriooxy)iron Chemical compound [Ba]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O AJCDFVKYMIUXCR-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/06—Ferric oxide (Fe2O3)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
- C01B13/14—Methods for preparing oxides or hydroxides in general
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
- C09C1/22—Compounds of iron
- C09C1/24—Oxides of iron
- C09C1/245—Oxides of iron of plate-like shape
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/50—Solid solutions
- C01P2002/52—Solid solutions containing elements as dopants
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/20—Particle morphology extending in two dimensions, e.g. plate-like
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/54—Particles characterised by their aspect ratio, i.e. the ratio of sizes in the longest to the shortest dimension
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/42—Magnetic properties
Definitions
- the present invention relates to a method of preparing a hematite platelet, a hematite platelet prepared using the same, and a hematite platelet pigment including the hematite platelet, and more particularly, to a method of preparing a hematite platelet that is suitable for use as a metallic pigment and has an aspect ratio of 20 or greater, a hematite platelet prepared using the same, and a hematite platelet pigment including the hematite platelet.
- Hematite is the most ⁇ mmon type of naturally occurring iron oxide mineral, and has been used as a colorant for centuries.
- examples of hematites include hematites, pyrites, and magnetites, which are respectively red-colored, yellow-colored, and black- colored.
- Wall paintings painted with hematites remain in caves all over the world, and retain their original color tones.
- these hematites are mostly prepared as synthetic products, and thus are used in various fields as pigments having clear color tones and excellent durability, being inexpensive and having low toxicity and high stability.
- hematites are applied to a variety of products, such as paints, inks, rubbers, plastics, paper, glass, cement, and the like. Further, high purity hematites are not harmful to humans, and thus can be used in foods, medicines, and cosmetics.
- well-known synthetic hematite pigments include red or red brown- colored hematite particle powder ( ⁇ -Fe 2 O 3 or micaceous iron oxide (MIO)), yellow or deep brown-colored maghemite ( ⁇ -Fe 2 O 3 ) particle powder, and black-colored magnetite (FeOx-Fe 2 O 3 where 0 ⁇ x ⁇ l).
- hematite pigments [5] Among these hematite pigments, a hematite pigment (hereinafter, referred to as
- hematite platelet in the form of a platelet, in particular, hematite is formed as a thin plate having a thickness of several /M to 10 /M due to the shape of hematite, and thus can be arranged in the form of layers during coating.
- hematite platelet has excellent coating properties (protection from the external environment). Therefore, hematite platelet can be used as a rust inhibiting pigment for steel structures, paint for protecting woods, and a print ink for plywood.
- hematite that has a small particle size and is transparent is used as a coloring pigment for metallic paints, for example, vehicles, by using its metallic gloss properties.
- hematite has ultraviolet-ray absorbing properties and covering properties with respect to skin (skin covering effect), and thus is useful as a material for forming films for packaging foods, colorants for medicine containers, and an extender for cosmetics.
- metallic pigments such as extenders for cosmetics may have sliding properties and adhesiveness, thereby facilitating good skin filling, and inhibiting excessive gloss, and thus prevents occurrence of unwanted gloss by reflective light, and have appropriate covering effects based on semi-transparency and natural color tones with respect to the skin.
- Metallic pigments in particular, should have low gloss by adjusting gloss properties, and also have color tones by interference.
- metallic pigments should have a particle size of at least 1 ⁇ m or greater, and an aspect ratio, which is defined as a ratio of particle size to thickness of pigment particles, of at least 10 or greater.
- a conventional hematite platelet is prepared using a dry method or a wet method.
- Examples of the wet method include a melting method and a hydrothermal synthesis method.
- the dry method generates large amounts of sulfur dioxide gases and sulfuric acid gases, thus requiring expensive antipollution measures. Therefore, the dry method is rarely used.
- the melting method which is one of the wet methods, an iron sulfate or iron chloride solution reacts with alkali, thereby producing magnetite or goethite, and the resultant is sintered to obtain hematite platelets.
- Korean Patent Publication No. 1992-11922 discloses a method of co-precipitating a bariun ion and an iron ion, and then heat treating the resultant.
- the bariun ion and the iron ion are co- precipitated in the form of hydroxide or carbonate, and heat treated at a temperature of 900 0 C or greater to prepare hexagonal plate-shaped bariun ferrite particulates having a size of 0.2 ⁇ 0.5/M.
- US 4,867,795 discloses a method of preparing hematite in the form of which Mn or Al is employed by synthesiang FeSO 4 as a raw material and a precursor comprising Al(OH) 3 , KMnO 4 , and NaAlO 2 in an autoclave.
- the hematite prepared using this method has a good aspect ratio, i.e., 20 or greater.
- the synthesis temperature is over 800 0 C.
- Japanese Patent Laid-open No. Sho 55-154319 discloses a method of economically preparing ⁇ -Fe 2 O 3 by hydro- thermally treating iron oxide such as iron ore as a raw material with an oxidant in an aqueous alkali solution via magnetite.
- EPAO 180881 discloses a method of preparing Ci-Fe 2 O 3 by using Fe(NO 3 )
- Japanese Patent Laid-open No. Sho 58-69730 discloses a method of efficiently preparing particles in the form of platelet by hydrothermally treating ⁇ -Fe 2 O 3 alone in an aqueous alkali solution.
- Japanese Patent Laid-open No. Hei 6-166520 discloses a method of preparing hematite platelet particulates in which aluninum is employed, the method including: mixing an aqueous iron (II) salt solution, an aqueous aluninum salt solution and an aqueous carbonate salt solution to obtain hydrotal ⁇ te-type particulates in the form of platelet, ⁇ mprising Fe 2+ and Al 3+ , and hydrothermally treating the particulates.
- II aqueous iron
- Al 3+ aqueous carbonate salt solution
- hematite particles having a desired aspect ratio can be obtained, and can be mass-produced.
- dis- persibility of the hematite particles is not good in a solution, and thus it is difficult to adjust the size of hematite particles, it is difficult to obtain particles in the form of platelet, and the sintering process is performed at a temperature of at least 800 0 C or greater.
- particles are sintered with each other, and this method is non- eooncmical.
- barium ferrite platelets have magnetic properties, and thus are not suitable as a pearl pigment.
- hematite platelets can be prepared at a relatively low temperature, particles are not sintered with each other, and it is easy to adjust the size of particles.
- the hydrothermal synthesis method is mainly suitable for preparing nano-sized hematite particles, but is not suitable for preparing metallic pigments such as pigments for cosmetics, which should have micro-sized particles or more.
- the hematite platelet prepared using this method has a small aspect ratio, i.e., in a range of 2 ⁇ 10, and thus cannot satisfy requirements for a metallic pigment or a pearl pigment, in terms of, for example, optical properties and adhesiveness.
- the present invention provides a method of preparing a hematite platelet using a hy- drothermal synthesis method, whereby the hematite platelet has an aspect ratio of 20 or greater in order to have low gloss and color tone by interference, which are properties suitable as a metallic pigment, and a hematite platelet prepared using the method.
- the present invention also provides a hematite platelet pigment including the hematite platelet.
- a hematite platelet having a particle size of l ⁇ 100/M, a particle thickness of 0.3 ⁇ 4/M, and an aspect ratio of 20 or greater can be prepared.
- FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention
- FIG. 2 is a scanning electron microscopic (SEM) image of a side surface of hematite platelet particles prepared in Experimental Example 1-4 ;
- FIG. 3A is a SEM image of a top surface of the hematite platelet particles of FIG. 2;
- FIG. 3B is an optical microscopic image of a top surface of the hematite platelet particles of FIG. 2;
- FIG. 4 illustrates particle size distribution of the hematite platelet of FIG. 2
- FIG. 5 illustrates X-ray diffraction (XRD) patterns of the hematite platelet powder of
- FIG. 2
- FIG. 6 is a SEM image of a side surface of hematite platelet particles prepared in Experimental Example 2- 1 ;
- FIG. 7 is a SEM image of a side surface of hematite platelet particles prepared in Experimental Example 3-4;
- FIG. 8 is a transmission electron microscopic (TEM) image of particle size and shape of a nanoparticle hematite seed
- FIG. 9 is a SEM image of a top surface of hematite platelet particles prepared using the hematite seed of FIG. 8;
- FIG. 10 is a SEM image of a side surface of hematite platelet particles of FIG. 2 on which TiO 2 is coated.
- FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention.
- the method of preparing a hematite platelet includes: preparing a hematite precursor aqueous solution ⁇ mprising iron(III) salt; an aqueous alkali solution; and an additive ⁇ mprising at least one selected from the group consisting of potassiun-based salts including potassiun phosphate, potassium sulfate, potassium chloride, potassiun nitrate, potassiun carbonate, potassium hydrogen carbonate, potassium bromide, and potassium fluoride, sodiun-based salts having the same anion as that of the potassiun- based salts, lithium-based salts, and calcium-based salts (operation SlO); uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product ⁇ mprising Fe +3 and at least one of K +
- the iron(III) salt used herein is not particularly limited, and can be any salt containing Fe +3 ions.
- the iron(III) salt may be iron (III) chloride (FeCl 3 ), iron(III) sulfate (Fe 2 (SO 4 ) 3 ), or iron(III) nitrate (Fe(NO 3 ) 3 ) and these salts can be used alone or in mixtures thereof.
- the aqueous alkali solution may be any one of potassiun hydroxide, sodiun hydroxide, calcium hydroxide, and lithiun hydroxide, which are general aqueous alkali solutions, or a mixture of at least two of these materials.
- the aqueous alkali solution is generally used in a wet preparation method of hematite, and, in the present invention, the aqueous alkali solution adjusts pH and alkali-neutralizes the iron(III) salt.
- the hematite precursor aqueous solution may have a pH of 11 or greater, and preferably a pH of 13 or greater in order to obtain the intermediate product ⁇ mprising Fe +3 and at least one of K + , Na + , Li + , and Ca + as an additive, which will be described later. If the pH of the hematite precursor aqueous solution is less than 11, it is difficult to produce the intermediate product.
- the aqueous alkali solution may be mixed by appropriately changing the amount of aqueous alkali solution.
- the aqueous alkali solution added in operation SlO reacts with Fe +3 to produce an initial product of Fe(OH) 3
- the aqueous alkali solution added in operation S20 reacts with a cation of the additive to produce an intermediate product of alkali-based hematite.
- the aqueous alkali solutions of operations SlO and S20 are distinguished from each other.
- the amount of aqueous alkali solution added may be in a range of
- the amount of aqueous alkali solution added may be in a range of 30 ⁇ 900 parts by weight, and preferably in a range of 50 ⁇ 600 parts by weight, with respect to 100 parts by weight of the iron(III) salt, in order to produce each of the initial product and the intermediate product.
- the additive of the present invention is ionized in a mixed solution as in the form of at least one of K + , Na + , Li + , and Ca + .
- the additive is employed in the form of amorphous alkali-based hematite, constituting the intermediate product, for example, K x Fe y O z where x and y are each an integer in the range of 1-2, and z is an integer in the range of 1-4, together with Fe +3 ions of the iron(III) salt, or employed in nano-sized Ci-Fe 2 O 3 , constituting a final product.
- the additive acts as a seed in crystallization of hematite platelet particles.
- the hematite mixture K x Fe y O z reacts with the final product, nano-sized Ci-Fe 2 O 3 to grow the hematite platelet particles.
- an alkali-based metal salt comprising at least one ion of K + , Na + , Li + , and Ca +
- the aspect ratio of the hematite platelet particles is constant and the size thereof is increased.
- colors of hematite platelet pigment can be various.
- hematite platelet crystals having a variety of aspect ratios may be prepared according to the amount of the additive in the form of neutral alkali-based metal salts.
- the amount of additive in the form of neutral alkali-based metal salts may be in a range of 0.01 ⁇ 4 parts by weight, and preferably in a range of 0.05 ⁇ 4 parts by weight, with respect to 100 parts by weight of the iron (III) salt.
- the amount of additive is less than 0.01 parts by weight with respect to 100 parts by weight of the iron (III) salt, it is difficult to obtain an aspect ratio of 10 or greater.
- the amount of additive is greater than 4 parts by weight with respect to 100 parts by weight of the iron (III) salt, the size of the obtained hematite platelet is small.
- the additive may be di-ethanol amine, tri-ethanol amine, a chelate organic ⁇ mpound, or the like, ⁇ mprising K + , Na + , Li + , or Ca + , in addition to the potassium-based salt, the sodiun-based salt, the lithiun-based salt, and the cal ⁇ un- based salt described above.
- the hematite platelet may be prepared by adding uniform nanoparticle hematite seed having a size of l ⁇ 50 nm to the hematite precursor aqueous solution in operation SlO. This method ⁇ mprises growing hematite platelet crystals by adding nanometer- sized hematite particles as a seed of crystallization in an initial stage of the process.
- the amount of hematite seed added may be in a range of 0.001 ⁇ 1 parts by weight, and preferably in a range of 0.005 ⁇ 0.2 parts by weight, with respect to 100 parts by weight of the iron(III) salt.
- the amount of hematite seed added is less than 0.001 parts by weight with respect to 100 parts by weight of the iron(III) salt, effects on the aspect ratio and dispersion of hematite platelet are insignificant.
- the amount of hematite seed added is greater than 1 part by weight with respect to 100 parts by weight of the iron(III) salt, hematite particles are too small to easily obtain hematite platelet having an effective aspect ratio.
- Operation S20 ⁇ mprising uniformly mixing the hematite precursor aqueous solution, may be performed by stirring the obtained hematite mixed solution at a rotating speed of 200 rpm or greater, or using one of a homogenizer, a ball miller, a static mixer, ultrasonic waves, and a microwave device, or using at least two of these devices in ⁇ mbination.
- Operation S30 may be performed using an autoclave device at a temperature in a range of 150 ⁇ 250°C for 2 ⁇ 240 hours.
- the greater the concentration of alkali the lower the reaction temperature that produces hematite platelet particles.
- the reaction temperature is less than 15O 0 C, it is difficult to obtain hematite platelet particles.
- an appropriate upper limit temperature may be 25O 0 C.
- the intermediate product produced in operation S20 acts as a seed of crystal, thereby producing hematite platelet ( ⁇ -Fe 2 O 3 ) crystal in which K, Na, Li, or Ca is employed by hydrothermal reaction.
- the method of preparing a hematite platelet may further include filtering, washing and drying the hematite platelet particles (operation S40) in order to obtain hematite platelet particles having a desired size and thickness.
- the size of hematite platelet particles prepared may be in a range of l ⁇ 100 ⁇ m, and preferably in a range of 5 ⁇ 80 ⁇ m. When the size of the particles is less than 1 ⁇ m, reflectance is decreased. On the other hand, when the size of the particles is greater than 100 ⁇ m, the hematite platelet particles are not suitable as a metallic pigment.
- the hematite platelet may have an aspect ratio of 20 or greater, and preferably an aspect ratio of 25 or greater.
- the aspect ratio of the hematite platelet is less than 20, it is difficult to produce interference colors as an optical property and adhesiveness of particles is decreased, resulting in poor use thereof.
- An upper limit of the aspect ratio is not limited, but when the aspect ratio of the hematite platelet is greater than 100, strong particle gloss may be realized.
- a hematite platelet pigment with metallic gloss in which the synthesized hematite platelet is used as a base and metal oxide is coated on the base is manufactured to prepare, for example, a pearl pigment with strong metallic effect.
- the hematite platelet pigment may be prepared, for example, by suspending the hematite platelet obtained using the preparation method as described above in deionized water, adding an acid such as hydrochloric acid or sulfuric acid to the resultant and stirring, simultaneously adding a metal chloride solution and an aqueous alkali solution to the aqueous solution and refluxing the resultant to prepare a hematite platelet particle aqueous solution coated with a metal oxide hydrate layer, and filtering, washing, drying and sintering the hematite platelet particle aqueous solution.
- an acid such as hydrochloric acid or sulfuric acid
- the metal oxide coated on the surface of the hematite platelet is a metal oxide typically coated on the surface of pigment and used to produce metallic gloss and interference colors in the field of preparing metallic pigments.
- the metal oxide is not particularly limited, and may be, in particular, SnO 2 , TiO 2 , ZrO 2 , SiO 2 , Al 2 O 3 , MgO, or MnO 2 , or at least two of these materials.
- such a multi-layer coating structure may include a coating layer formed of SiO 2 , and a TiO 2 coating layer formed on the surface of the SiO 2 ⁇ x>ating layer.
- the advantages of such a multi-layer coating structure are an increase in covering power and obtainment of high-quality interference colors.
- FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention.
- the method of preparing a hematite platelet includes: preparing a hematite precursor aqueous solution comprising iron(III) salt; an aqueous alkali solution; and an additive comprising at least one selected from the group consisting of potassiun-based salts including potassiun phosphate, potassium sulfate, potassium chloride, potassiun nitrate, potassiun carbonate, potassium hydrogen carbonate, potassium bromide, and potassium fluoride, sodiun-based salts having the same anion as that of the potassiun- based salts, lithium-based salts, and calcium-based salts (operation SlO); uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product comprising Fe +3 and at least one of K + , Na + , Li + , and Ca
- the iron(III) salt used herein is not particularly limited, and can be any salt containing Fe +3 ions.
- the iron(III) salt may be iron(III) chloride (FeCl 3 ), iron(III) sulfate (Fe 2 (SO 4 ) 3 ), or iron(III) nitrate (Fe(NO 3 ) 3 ) and these salts can be used alone or in mixtures thereof.
- the aqueous alkali solution may be any one of potassiun hydroxide, sodiun hydroxide, calcium hydroxide, and lithiun hydroxide, which are general aqueous alkali solutions, or a mixture of at least two of these materials.
- the aqueous alkali solution is generally used in a wet preparation method of hematite, and, in the present invention, the aqueous alkali solution adjusts pH and alkali-neutralizes the iron(III) salt.
- the hematite precursor aqueous solution may have a pH of 11 or greater, and preferably a pH of 13 or greater in order to obtain the intermediate product comprising Fe +3 and at least one of K + , Na + , Li + , and Ca + as an additive, which will be described later. If the pH of the hematite precursor aqueous solution is less than 11, it is difficult to produce the intermediate product.
- the aqueous alkali solution may be mixed by appropriately changing the amount of aqueous alkali solution.
- the aqueous alkali solution added in operation SlO reacts with Fe +3 to produce an initial product of Fe(OH) 3
- the aqueous alkali solution added in operation S20 reacts with a cation of the additive to produce an intermediate product of alkali-based hematite.
- the aqueous alkali solutions of operations SlO and S20 are distinguished from each other.
- the amount of aqueous alkali solution added may be in a range of
- the amount of aqueous alkali solution added may be in a range of 30 ⁇ 900 parts by weight, and preferably in a range of 50 ⁇ 600 parts by weight, with respect to 100 parts by weight of the iron(III) salt, in order to produce each of the initial product and the intermediate product.
- the additive of the present invention is ionized in a mixed solution as in the form of at least one of K + , Na + , Li + , and Ca + .
- the additive is employed in the form of amorphous alkali-based hematite, constituting the intermediate product, for example, K x Fe y O z where x and y are each an integer in the range of 1-2, and z is an integer in the range of 1-4, together with Fe +3 ions of the iron(III) salt, or employed in nano-sized Ci-Fe 2 O 3 , constituting a final product.
- the additive acts as a seed in crystallization of hematite platelet particles.
- the hematite mixture K x Fe y O z reacts with the final product, nano-sized Ci-Fe 2 O 3 to grow the hematite platelet particles.
- an alkali-based metal salt comprising at least one ion of K + , Na + , Li + , and Ca +
- the aspect ratio of the hematite platelet particles is constant and the size thereof is increased.
- colors of hematite platelet pigment can be various.
- hematite platelet crystals having a variety of aspect ratios may be prepared according to the amount of the additive in the form of neutral alkali-based metal salts.
- the additive adheres to the crystal surface of the hematite platelet in the crystallization process, thereby facilitating the growth of the hematite platelet in a size direction and relatively inhibiting the growth of the hematite platelet in a thickness direction.
- the additive forms hematite platelet crystals having similar size and effectively decreased thickness.
- the amount of additive in the form of neutral alkali-based metal salts may be in a range of 0.01 ⁇ 4 parts by weight, and preferably in a range of 0.05 ⁇ 4 parts by weight, with respect to 100 parts by weight of the iron (III) salt. If the amount of additive is less than 0.01 parts by weight with respect to 100 parts by weight of the iron (III) salt, it is difficult to obtain an aspect ratio of 10 or greater. On the other hand, if the amount of additive is greater than 4 parts by weight with respect to 100 parts by weight of the iron (III) salt, the size of the obtained hematite platelet is small.
- the additive may be di-ethanol amine, tri-ethanol amine, a chelate organic ⁇ mpound, or the like, ⁇ mprising K + , Na + , Li + , or Ca + , in addition to the potassium-based salt, the sodiun-based salt, the lithiun-based salt, and the cal ⁇ un- based salt described above.
- the hematite platelet may be prepared by adding uniform nanoparticle hematite seed having a size of l ⁇ 50 nm to the hematite precursor aqueous solution in operation SlO. This method ⁇ mprises growing hematite platelet crystals by adding nanometer- sized hematite particles as a seed of crystallization in an initial stage of the process.
- the amount of hematite seed added may be in a range of 0.001 ⁇ 1 parts by weight, and preferably in a range of 0.005 ⁇ 0.2 parts by weight, with respect to 100 parts by weight of the iron(III) salt.
- the amount of hematite seed added is less than 0.001 parts by weight with respect to 100 parts by weight of the iron(III) salt, effects on the aspect ratio and dispersion of hematite platelet are insignificant.
- the amount of hematite seed added is greater than 1 part by weight with respect to 100 parts by weight of the iron(III) salt, hematite particles are too small to easily obtain hematite platelet having an effective aspect ratio.
- Operation S20 ⁇ mprising uniformly mixing the hematite precursor aqueous solution, may be performed by stirring the obtained hematite mixed solution at a rotating speed of 200 rpm or greater, or using one of a homogenizer, a ball miller, a static mixer, ultrasonic waves, and a microwave device, or using at least two of these devices in ⁇ mbination.
- Operation S30 may be performed using an autoclave device at a temperature in a range of 150 ⁇ 250°C for 2 ⁇ 240 hours.
- the greater the concentration of alkali the lower the reaction temperature that produces hematite platelet particles.
- the reaction temperature is less than 15O 0 C, it is difficult to obtain hematite platelet particles.
- an appropriate upper limit temperature may be 25O 0 C.
- the intermediate product produced in operation S20 acts as a seed of crystal, thereby producing hematite platelet ( ⁇ -Fe 2 O 3 ) crystal in which K, Na, Li, or Ca is employed by hydrothermal reaction.
- the method of preparing a hematite platelet may further include filtering, washing and drying the hematite platelet particles (operation S40) in order to obtain hematite platelet particles having a desired size and thickness.
- the size of hematite platelet particles prepared may be in a range of l ⁇ 100 ⁇ m, and preferably in a range of 5 ⁇ 80 ⁇ m. When the size of the particles is less than 1 ⁇ m, reflectance is decreased. On the other hand, when the size of the particles is greater than 100 ⁇ m, the hematite platelet particles are not suitable as a metallic pigment.
- the hematite platelet may have an aspect ratio of 20 or greater, and preferably an aspect ratio of 25 or greater.
- the aspect ratio of the hematite platelet is less than 20, it is difficult to produce interference colors as an optical property and adhesiveness of particles is decreased, resulting in poor use thereof.
- An upper limit of the aspect ratio is not limited, but when the aspect ratio of the hematite platelet is greater than 100, strong particle gloss may be realized.
- a hematite platelet pigment with metallic gloss in which the synthesized hematite platelet is used as a base and metal oxide is coated on the base is manufactured to prepare, for example, a pearl pigment with strong metallic effect.
- the hematite platelet pigment may be prepared, for example, by suspending the hematite platelet obtained using the preparation method as described above in deionized water, adding an acid such as hydrochloric acid or sulfuric acid to the resultant and stirring, simultaneously adding a metal chloride solution and an aqueous alkali solution to the aqueous solution and refluxing the resultant to prepare a hematite platelet particle aqueous solution coated with a metal oxide hydrate layer, and filtering, washing, drying and sintering the hematite platelet particle aqueous solution.
- an acid such as hydrochloric acid or sulfuric acid
- the metal oxide coated on the surface of the hematite platelet is a metal oxide typically coated on the surface of pigment and used to produce metallic gloss and interference colors in the field of preparing metallic pigments.
- the metal oxide is not particularly limited, and may be, in particular, SnO 2 , TiO 2 , ZrO 2 , SiO 2 , Al 2 O 3 , MgO, or MnO 2 , or at least two of these materials. More preferably, it is desirable to form a multi-layer coating structure by using a variety of metal oxides.
- such a multi-layer coating structure may include a coating layer formed of SiO 2 , and a TiO 2 coating layer formed on the surface of the SiO 2 ⁇ x>ating layer.
- the mixed solution was prepared by uniformly mixing at 200 rpm or greater by using an agitator. Then the mixture was put in a hydrothermal reactor and heated at 17O 0 C for 20 hours. After the hydrothermal reaction was terminated, the hydrothermal reactor was cooled down at room temperature. Then the reactor was washed using distilled water more than 3 times and dried at 6O 0 C for 1 day to obtain a final product.
- FIG. 3A is a SEM image of the overall shape of the hematite platelet particles of FIG. 2, and FIG.
- FIG. 3B is an optical microscopic image of a top surface of the hematite platelet particles of Experimental Example 1-4 .
- the particles have hexahedron-like crystal shapes in the form of platelet and red purple-colored monocrystals.
- FIG. 4 illustrates particle size distribution of the hematite platelet of FIG. 2 measured using a particle size analyzer (Malvern Co.). The particle sizes D 10 , D 50 , and D 90 were measured as 9 ⁇ m, 17 ⁇ m, and 25 ⁇ m, respectively.
- FIG. 5 illustrates X-ray diffraction analysis results of the hematite platelet powder of FIG. 2. As a result of the estimation of crystallization, it was confirmed that the product was hematite ( ⁇ -Fe 2 O 3 , JCPDS No. 86-0550).
- hematite platelet precursor mixed solution 120 g of water was stirred to prepare a hematite platelet precursor mixed solution.
- potassium hydroxide was further added to the hematite platelet precursor mixed solution by changing the amount thereof in a range of 6-60 g to change the (imposition ratio.
- the mixed solution was prepared by uniformly mixing at 200 rpm or greater by using an agitator. Then the mixture was put in a hydrothermal reactor and heated at 17O 0 C for 20 hours. After the hydrothermal reaction was terminated, the hydrothermal reactor was oooled down at room temperature. Then the reactor was washed using distilled water more than 3 times and dried at 6O 0 C for 1 day to obtain a final product.
- Hematite platelet was prepared in the same manner as in Experimental Example 2.
- FIG. 8 is a transmission electron microsGopic (TEM) image of a nanoparticle hematite seed used in Experimental Example 4.
- FIG. 9 is a SEM image of hematite platelet particle powder prepared in the same manner as in Experimental Example 2, by adding the nanoparticle hematite seed of FIG. 8 in an amount of 0.01 parts by weight with respect to 100 parts by weight of iron(III) salt.
- TEM transmission electron microsGopic
- Example 1 100 ⁇ 150 g of the hematite platelet particles prepared in Experimental Example 1-1 was suspended in 2L of deionized water, and then the temperature of the mixture was raised to 70 ⁇ 80°C. Then, a 5% hydrochloric acid was added to the mixture to adjust the pH of the mixture to 2, and the mixture was stirred for 30 minutes. Then, a 40% solution of TiOCl 2 and NaOH was added to the mixture to form a TiO(OH) 2 coating layer on the surface of the hematite platelet particles. As the amount of the solution of TiOCl 2 and NaOH to be added was increased, interference colors of gold, red, purple, blue, and green were exhibited.
- TiO 2 titanium dioxide
- FIG. 10 is a SEM image of the hematite platelet particles coated with the TiO 2 layer.
- the present invention relates to a hematite platelet, and a hematite platelet pigment including the hematite platelet ,.
- Hematite platelet can be used as a rust inhibiting pigment for steel structures, paint for protecting woods, and a print ink for plywood. Also, hematite that has a small particle size and is transparent is used as a coloring pigment for metallic paints, for example, vehicles, by using its metallic gloss properties.
- hematite has ultraviolet-ray absorbing properties and covering properties with respect to skin (skin covering effect), and thus is used as a material for forming films for packaging foods, colorants for medicine containers, and an extender for cosmetics.
Abstract
Provided are a method of preparing a hematite platelet, a hematite platelet prepared using the method, and a hematite platelet pigment including the hematite platelet. The method of preparing a hematite platelet includes: preparing a hematite precursor aqueous solution comprising iron(III) salt; an aqueous alkali solution; and an additive comprising alkali-based metal salts; uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product comprising Fe +3 and at least one of K+, Na+, Li+, and Ca+; and hydrothermally treating the hematite precursor aqueous solution. In addition, the hematite platelet pigment is prepared by using the hematite platelet prepared using the preparation method as a base and coating a metal oxide on the base. Moreover, a hematite platelet having a particle size of l~100μm, a particle thickness of 0.3~4μm, and an aspect ratio of 20 or greater can be prepared.
Description
Description
METHOD OF PREPARING HEMATITE PLATELET,
HEMATITE PLATELET PREPARED USING THE SAME, AND
HEMATITE PLATELET PIGMENT INCLUDING THE
HEMATITE PLATELET Technical Field
[1] The present invention relates to a method of preparing a hematite platelet, a hematite platelet prepared using the same, and a hematite platelet pigment including the hematite platelet, and more particularly, to a method of preparing a hematite platelet that is suitable for use as a metallic pigment and has an aspect ratio of 20 or greater, a hematite platelet prepared using the same, and a hematite platelet pigment including the hematite platelet.
[2]
Background Art
[3] Hematite is the most αmmon type of naturally occurring iron oxide mineral, and has been used as a colorant for centuries. Examples of hematites include hematites, pyrites, and magnetites, which are respectively red-colored, yellow-colored, and black- colored. Wall paintings painted with hematites remain in caves all over the world, and retain their original color tones. Currently, these hematites are mostly prepared as synthetic products, and thus are used in various fields as pigments having clear color tones and excellent durability, being inexpensive and having low toxicity and high stability. In this regard, hematites are applied to a variety of products, such as paints, inks, rubbers, plastics, paper, glass, cement, and the like. Further, high purity hematites are not harmful to humans, and thus can be used in foods, medicines, and cosmetics.
[4] In particular, well-known synthetic hematite pigments include red or red brown- colored hematite particle powder (α-Fe 2O3 or micaceous iron oxide (MIO)), yellow or deep brown-colored maghemite (γ-Fe 2O3) particle powder, and black-colored magnetite (FeOx-Fe2O3 where 0<x≤l).
[5] Among these hematite pigments, a hematite pigment (hereinafter, referred to as
"hematite platelet") in the form of a platelet, in particular, hematite is formed as a thin plate having a thickness of several /M to 10 /M due to the shape of hematite, and thus can be arranged in the form of layers during coating. Thus, hematite platelet has excellent coating properties (protection from the external environment). Therefore,
hematite platelet can be used as a rust inhibiting pigment for steel structures, paint for protecting woods, and a print ink for plywood. Also, hematite that has a small particle size and is transparent is used as a coloring pigment for metallic paints, for example, vehicles, by using its metallic gloss properties. In addition, hematite has ultraviolet-ray absorbing properties and covering properties with respect to skin (skin covering effect), and thus is useful as a material for forming films for packaging foods, colorants for medicine containers, and an extender for cosmetics.
[6] In particular, metallic pigments such as extenders for cosmetics may have sliding properties and adhesiveness, thereby facilitating good skin filling, and inhibiting excessive gloss, and thus prevents occurrence of unwanted gloss by reflective light, and have appropriate covering effects based on semi-transparency and natural color tones with respect to the skin. Metallic pigments, in particular, should have low gloss by adjusting gloss properties, and also have color tones by interference. Thus, to have these properties, metallic pigments should have a particle size of at least 1 μm or greater, and an aspect ratio, which is defined as a ratio of particle size to thickness of pigment particles, of at least 10 or greater.
[7] A conventional hematite platelet is prepared using a dry method or a wet method.
Examples of the wet method include a melting method and a hydrothermal synthesis method. The dry method generates large amounts of sulfur dioxide gases and sulfuric acid gases, thus requiring expensive antipollution measures. Therefore, the dry method is rarely used. In the melting method, which is one of the wet methods, an iron sulfate or iron chloride solution reacts with alkali, thereby producing magnetite or goethite, and the resultant is sintered to obtain hematite platelets.
[8] As an example of the melting method, Korean Patent Publication No. 1992-11922 discloses a method of co-precipitating a bariun ion and an iron ion, and then heat treating the resultant. In this method, the bariun ion and the iron ion are co- precipitated in the form of hydroxide or carbonate, and heat treated at a temperature of 9000C or greater to prepare hexagonal plate-shaped bariun ferrite particulates having a size of 0.2~0.5/M.
[9] In addition, US 4,867,795 discloses a method of preparing hematite in the form of which Mn or Al is employed by synthesiang FeSO 4 as a raw material and a precursor comprising Al(OH) 3, KMnO4, and NaAlO2 in an autoclave. The hematite prepared using this method has a good aspect ratio, i.e., 20 or greater. However, the synthesis temperature is over 8000C.
[10] As an example of the hydrothermal synthesis method, Japanese Patent Laid-open No.
Sho 55-154319 discloses a method of economically preparing α-Fe 2O3 by hydro- thermally treating iron oxide such as iron ore as a raw material with an oxidant in an aqueous alkali solution via magnetite.
[11] In addition, EPAO 180881 discloses a method of preparing Ci-Fe2O3 by using Fe(NO3)
3-9H2O as a raw material by hydrothermal synthesis.
[12] In addition, Japanese Patent Laid-open No. Sho 58-69730 discloses a method of efficiently preparing particles in the form of platelet by hydrothermally treating γ-Fe 2O3 alone in an aqueous alkali solution.
[13] In addition, Japanese Patent Laid-open No. Hei 6-166520 discloses a method of preparing hematite platelet particulates in which aluninum is employed, the method including: mixing an aqueous iron (II) salt solution, an aqueous aluninum salt solution and an aqueous carbonate salt solution to obtain hydrotalάte-type particulates in the form of platelet, αmprising Fe 2+ and Al3+, and hydrothermally treating the particulates.
[14]
Disclosure of Invention Technical Problem
[15] According to the melting method described above, hematite particles having a desired aspect ratio can be obtained, and can be mass-produced. However, dis- persibility of the hematite particles is not good in a solution, and thus it is difficult to adjust the size of hematite particles, it is difficult to obtain particles in the form of platelet, and the sintering process is performed at a temperature of at least 8000C or greater. Thus, particles are sintered with each other, and this method is non- eooncmical. In particular, barium ferrite platelets have magnetic properties, and thus are not suitable as a pearl pigment.
[16] According to the hydrothermal synthesis method, hematite platelets can be prepared at a relatively low temperature, particles are not sintered with each other, and it is easy to adjust the size of particles. The hydrothermal synthesis method is mainly suitable for preparing nano-sized hematite particles, but is not suitable for preparing metallic pigments such as pigments for cosmetics, which should have micro-sized particles or more.
[17] In particular, the hematite platelet prepared using this method has a small aspect ratio, i.e., in a range of 2~10, and thus cannot satisfy requirements for a metallic pigment or a pearl pigment, in terms of, for example, optical properties and adhesiveness.
[18]
Technical Solution
[19] The present invention provides a method of preparing a hematite platelet using a hy- drothermal synthesis method, whereby the hematite platelet has an aspect ratio of 20 or greater in order to have low gloss and color tone by interference, which are properties suitable as a metallic pigment, and a hematite platelet prepared using the method.
[20] The present invention also provides a hematite platelet pigment including the hematite platelet.
[21]
Advantageous Effects
[22] According to the present invention, a hematite platelet having a particle size of l~100/M, a particle thickness of 0.3~4/M, and an aspect ratio of 20 or greater can be prepared.
[23]
Brief Description of the Drawings
[24] The above and other features and advantages of the present invention will become more apparent by describing in detail exemplary embodiments thereof with reference to the attached drawings in which:
[25] FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention;
[26] FIG. 2 is a scanning electron microscopic (SEM) image of a side surface of hematite platelet particles prepared in Experimental Example 1-4 ;
[27] FIG. 3A is a SEM image of a top surface of the hematite platelet particles of FIG. 2;
[28] FIG. 3B is an optical microscopic image of a top surface of the hematite platelet particles of FIG. 2;
[29] FIG. 4 illustrates particle size distribution of the hematite platelet of FIG. 2;
[30] FIG. 5 illustrates X-ray diffraction (XRD) patterns of the hematite platelet powder of
FIG. 2;
[31] FIG. 6 is a SEM image of a side surface of hematite platelet particles prepared in Experimental Example 2- 1 ;
[32] FIG. 7 is a SEM image of a side surface of hematite platelet particles prepared in Experimental Example 3-4;
[33] FIG. 8 is a transmission electron microscopic (TEM) image of particle size and shape of a nanoparticle hematite seed;
[34] FIG. 9 is a SEM image of a top surface of hematite platelet particles prepared using the hematite seed of FIG. 8;
[35] FIG. 10 is a SEM image of a side surface of hematite platelet particles of FIG. 2 on which TiO2 is coated.
[36]
Best Mode for Carrying Out the Invention
[37] The present invention will now be described more fully with reference to the ac- αmpanying drawings, in which exemplary embodiments of the invention are shown.
[38] FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention. Referring to FIG. 1, the method of preparing a hematite platelet includes: preparing a hematite precursor aqueous solution αmprising iron(III) salt; an aqueous alkali solution; and an additive αmprising at least one selected from the group consisting of potassiun-based salts including potassiun phosphate, potassium sulfate, potassium chloride, potassiun nitrate, potassiun carbonate, potassium hydrogen carbonate, potassium bromide, and potassium fluoride, sodiun-based salts having the same anion as that of the potassiun- based salts, lithium-based salts, and calcium-based salts (operation SlO); uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product αmprising Fe +3 and at least one of K+, Na+, Li+, and Ca+ (operation S20); and hydro- thermally treating the hematite precursor aqueous solution (operation S30).
[39] The iron(III) salt used herein is not particularly limited, and can be any salt containing Fe+3 ions. Preferably, the iron(III) salt may be iron (III) chloride (FeCl3), iron(III) sulfate (Fe2(SO4)3), or iron(III) nitrate (Fe(NO3)3) and these salts can be used alone or in mixtures thereof.
[40] The aqueous alkali solution may be any one of potassiun hydroxide, sodiun hydroxide, calcium hydroxide, and lithiun hydroxide, which are general aqueous alkali solutions, or a mixture of at least two of these materials. The aqueous alkali solution is generally used in a wet preparation method of hematite, and, in the present invention, the aqueous alkali solution adjusts pH and alkali-neutralizes the iron(III) salt.
[41] The hematite precursor aqueous solution may have a pH of 11 or greater, and preferably a pH of 13 or greater in order to obtain the intermediate product αmprising Fe+3 and at least one of K+, Na+, Li+, and Ca+ as an additive, which will be described later. If the pH of the hematite precursor aqueous solution is less than 11, it is difficult to produce the intermediate product.
[42] In addition, in operations SlO and S20, the aqueous alkali solution may be mixed by appropriately changing the amount of aqueous alkali solution. The aqueous alkali solution added in operation SlO reacts with Fe+3 to produce an initial product of Fe(OH)3, whereas the aqueous alkali solution added in operation S20 reacts with a cation of the additive to produce an intermediate product of alkali-based hematite. Thus, the aqueous alkali solutions of operations SlO and S20 are distinguished from each other.
[43] In operation S20, the amount of aqueous alkali solution added may be in a range of
80~300 parts by weight, and preferably in a range of 100~200 parts by weight, with respect to 100 parts by weight of the iron(III) salt, and in operation SlO, the amount of aqueous alkali solution added may be in a range of 30~900 parts by weight, and preferably in a range of 50~600 parts by weight, with respect to 100 parts by weight of the iron(III) salt, in order to produce each of the initial product and the intermediate product.
[44] In addition, the additive of the present invention is ionized in a mixed solution as in the form of at least one of K+, Na+, Li+, and Ca+. The additive is employed in the form of amorphous alkali-based hematite, constituting the intermediate product, for example, KxFeyOz where x and y are each an integer in the range of 1-2, and z is an integer in the range of 1-4, together with Fe+3 ions of the iron(III) salt, or employed in nano-sized Ci-Fe2O3, constituting a final product. Thus, the additive acts as a seed in crystallization of hematite platelet particles. In addition, more particularly, the hematite mixture KxFeyOz reacts with the final product, nano-sized Ci-Fe2O3 to grow the hematite platelet particles. As an amount of an alkali-based metal salt comprising at least one ion of K+, Na+, Li+, and Ca+ is increased, the aspect ratio of the hematite platelet particles (particle size/thickness) is constant and the size thereof is increased. In addition, according to a processing temperature and processing method, colors of hematite platelet pigment can be various. In addition, hematite platelet crystals having a variety of aspect ratios may be prepared according to the amount of the additive in the form of neutral alkali-based metal salts.
[45] That is, after the additive is oxidized, the additive adheres to the crystal surface of the hematite platelet in the crystallization process, thereby facilitating the growth of the hematite platelet in a size direction and relatively inhibiting the growth of the hematite platelet in a thickness direction. Thus, compared with the case when hematite platelet is formed alone, the additive forms hematite platelet crystals having similar size and effectively decreased thickness.
[46] The amount of additive in the form of neutral alkali-based metal salts may be in a range of 0.01~4 parts by weight, and preferably in a range of 0.05~4 parts by weight, with respect to 100 parts by weight of the iron (III) salt. If the amount of additive is less than 0.01 parts by weight with respect to 100 parts by weight of the iron (III) salt, it is difficult to obtain an aspect ratio of 10 or greater. On the other hand, if the amount of additive is greater than 4 parts by weight with respect to 100 parts by weight of the iron (III) salt, the size of the obtained hematite platelet is small.
[47] In addition, the additive may be di-ethanol amine, tri-ethanol amine, a chelate organic αmpound, or the like, αmprising K +, Na+, Li+, or Ca+, in addition to the potassium-based salt, the sodiun-based salt, the lithiun-based salt, and the calάun- based salt described above.
[48] The hematite platelet may be prepared by adding uniform nanoparticle hematite seed having a size of l~50 nm to the hematite precursor aqueous solution in operation SlO. This method αmprises growing hematite platelet crystals by adding nanometer- sized hematite particles as a seed of crystallization in an initial stage of the process.
[49] The amount of hematite seed added may be in a range of 0.001 ~ 1 parts by weight, and preferably in a range of 0.005 ~0.2 parts by weight, with respect to 100 parts by weight of the iron(III) salt. When the amount of hematite seed added is less than 0.001 parts by weight with respect to 100 parts by weight of the iron(III) salt, effects on the aspect ratio and dispersion of hematite platelet are insignificant. On the other hand, when the amount of hematite seed added is greater than 1 part by weight with respect to 100 parts by weight of the iron(III) salt, hematite particles are too small to easily obtain hematite platelet having an effective aspect ratio.
[50] Operation S20, αmprising uniformly mixing the hematite precursor aqueous solution, may be performed by stirring the obtained hematite mixed solution at a rotating speed of 200 rpm or greater, or using one of a homogenizer, a ball miller, a static mixer, ultrasonic waves, and a microwave device, or using at least two of these devices in αmbination.
[51] Operation S30 may be performed using an autoclave device at a temperature in a range of 150~250°C for 2~240 hours. In general, the greater the concentration of alkali, the lower the reaction temperature that produces hematite platelet particles. When the reaction temperature is less than 15O0C, it is difficult to obtain hematite platelet particles. On the other hand, when the reaction temperature is greater than 25O0C, the hematite platelet particles can be obtained, but in order for stable operation of a hydrothermal treatment device and economically preparing hematite platelet, an
appropriate upper limit temperature may be 25O0C.
[52] In operation S30, the intermediate product produced in operation S20 acts as a seed of crystal, thereby producing hematite platelet (α-Fe 2O3) crystal in which K, Na, Li, or Ca is employed by hydrothermal reaction.
[53] In addition, after operation S30, the method of preparing a hematite platelet may further include filtering, washing and drying the hematite platelet particles (operation S40) in order to obtain hematite platelet particles having a desired size and thickness.
[54] The size of hematite platelet particles prepared may be in a range of l~100 μm, and preferably in a range of 5 ~ 80 μm. When the size of the particles is less than 1 μm, reflectance is decreased. On the other hand, when the size of the particles is greater than 100 μm, the hematite platelet particles are not suitable as a metallic pigment.
[55] In addition, the hematite platelet may have an aspect ratio of 20 or greater, and preferably an aspect ratio of 25 or greater. When the aspect ratio of the hematite platelet is less than 20, it is difficult to produce interference colors as an optical property and adhesiveness of particles is decreased, resulting in poor use thereof. An upper limit of the aspect ratio is not limited, but when the aspect ratio of the hematite platelet is greater than 100, strong particle gloss may be realized.
[56] A hematite platelet pigment with metallic gloss in which the synthesized hematite platelet is used as a base and metal oxide is coated on the base is manufactured to prepare, for example, a pearl pigment with strong metallic effect.
[57] The hematite platelet pigment may be prepared, for example, by suspending the hematite platelet obtained using the preparation method as described above in deionized water, adding an acid such as hydrochloric acid or sulfuric acid to the resultant and stirring, simultaneously adding a metal chloride solution and an aqueous alkali solution to the aqueous solution and refluxing the resultant to prepare a hematite platelet particle aqueous solution coated with a metal oxide hydrate layer, and filtering, washing, drying and sintering the hematite platelet particle aqueous solution.
[58] The metal oxide coated on the surface of the hematite platelet is a metal oxide typically coated on the surface of pigment and used to produce metallic gloss and interference colors in the field of preparing metallic pigments. The metal oxide is not particularly limited, and may be, in particular, SnO 2, TiO2, ZrO2, SiO2, Al2O3, MgO, or MnO2, or at least two of these materials.
[59] More preferably, it is desirable to form a multi-layer coating structure by using a variety of metal oxides. For example, such a multi-layer coating structure may include a coating layer formed of SiO 2, and a TiO2 coating layer formed on the surface of the
SiO2<x>ating layer. The advantages of such a multi-layer coating structure are an increase in covering power and obtainment of high-quality interference colors.
[60]
Mode for the Invention
[61] The present invention will now be described more fully with reference to the accompanying drawings, in which exemplary embodiments of the invention are shown.
[62] FIG. 1 is a flowchart sequentially illustrating a method of preparing a hematite platelet, according to an embodiment of the present invention. Referring to FIG. 1, the method of preparing a hematite platelet includes: preparing a hematite precursor aqueous solution comprising iron(III) salt; an aqueous alkali solution; and an additive comprising at least one selected from the group consisting of potassiun-based salts including potassiun phosphate, potassium sulfate, potassium chloride, potassiun nitrate, potassiun carbonate, potassium hydrogen carbonate, potassium bromide, and potassium fluoride, sodiun-based salts having the same anion as that of the potassiun- based salts, lithium-based salts, and calcium-based salts (operation SlO); uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product comprising Fe +3 and at least one of K+, Na+, Li+, and Ca+ (operation S20); and hydro- thermally treating the hematite precursor aqueous solution (operation S30).
[63] The iron(III) salt used herein is not particularly limited, and can be any salt containing Fe+3 ions. Preferably, the iron(III) salt may be iron(III) chloride (FeCl3), iron(III) sulfate (Fe2(SO4)3), or iron(III) nitrate (Fe(NO3)3) and these salts can be used alone or in mixtures thereof.
[64] The aqueous alkali solution may be any one of potassiun hydroxide, sodiun hydroxide, calcium hydroxide, and lithiun hydroxide, which are general aqueous alkali solutions, or a mixture of at least two of these materials. The aqueous alkali solution is generally used in a wet preparation method of hematite, and, in the present invention, the aqueous alkali solution adjusts pH and alkali-neutralizes the iron(III) salt.
[65] The hematite precursor aqueous solution may have a pH of 11 or greater, and preferably a pH of 13 or greater in order to obtain the intermediate product comprising Fe+3 and at least one of K+, Na+, Li+, and Ca+ as an additive, which will be described later. If the pH of the hematite precursor aqueous solution is less than 11, it is difficult to produce the intermediate product.
[66] In addition, in operations SlO and S20, the aqueous alkali solution may be mixed by appropriately changing the amount of aqueous alkali solution. The aqueous alkali
solution added in operation SlO reacts with Fe+3 to produce an initial product of Fe(OH)3, whereas the aqueous alkali solution added in operation S20 reacts with a cation of the additive to produce an intermediate product of alkali-based hematite. Thus, the aqueous alkali solutions of operations SlO and S20 are distinguished from each other.
[67] In operation S20, the amount of aqueous alkali solution added may be in a range of
80~300 parts by weight, and preferably in a range of 100~200 parts by weight, with respect to 100 parts by weight of the iron(III) salt, and in operation SlO, the amount of aqueous alkali solution added may be in a range of 30~900 parts by weight, and preferably in a range of 50~600 parts by weight, with respect to 100 parts by weight of the iron(III) salt, in order to produce each of the initial product and the intermediate product.
[68] In addition, the additive of the present invention is ionized in a mixed solution as in the form of at least one of K+, Na+, Li+, and Ca+. The additive is employed in the form of amorphous alkali-based hematite, constituting the intermediate product, for example, KxFeyOz where x and y are each an integer in the range of 1-2, and z is an integer in the range of 1-4, together with Fe+3 ions of the iron(III) salt, or employed in nano-sized Ci-Fe2O3, constituting a final product. Thus, the additive acts as a seed in crystallization of hematite platelet particles. In addition, more particularly, the hematite mixture KxFeyOz reacts with the final product, nano-sized Ci-Fe2O3 to grow the hematite platelet particles. As an amount of an alkali-based metal salt comprising at least one ion of K+, Na+, Li+, and Ca+ is increased, the aspect ratio of the hematite platelet particles (particle size/thickness) is constant and the size thereof is increased. In addition, according to a processing temperature and processing method, colors of hematite platelet pigment can be various. In addition, hematite platelet crystals having a variety of aspect ratios may be prepared according to the amount of the additive in the form of neutral alkali-based metal salts.
[69] That is, after the additive is oxidized, the additive adheres to the crystal surface of the hematite platelet in the crystallization process, thereby facilitating the growth of the hematite platelet in a size direction and relatively inhibiting the growth of the hematite platelet in a thickness direction. Thus, compared with the case when hematite platelet is formed alone, the additive forms hematite platelet crystals having similar size and effectively decreased thickness.
[70] The amount of additive in the form of neutral alkali-based metal salts may be in a range of 0.01~4 parts by weight, and preferably in a range of 0.05~4 parts by weight,
with respect to 100 parts by weight of the iron (III) salt. If the amount of additive is less than 0.01 parts by weight with respect to 100 parts by weight of the iron (III) salt, it is difficult to obtain an aspect ratio of 10 or greater. On the other hand, if the amount of additive is greater than 4 parts by weight with respect to 100 parts by weight of the iron (III) salt, the size of the obtained hematite platelet is small.
[71] In addition, the additive may be di-ethanol amine, tri-ethanol amine, a chelate organic αmpound, or the like, αmprising K +, Na+, Li+, or Ca+, in addition to the potassium-based salt, the sodiun-based salt, the lithiun-based salt, and the calάun- based salt described above.
[72] The hematite platelet may be prepared by adding uniform nanoparticle hematite seed having a size of l~50 nm to the hematite precursor aqueous solution in operation SlO. This method αmprises growing hematite platelet crystals by adding nanometer- sized hematite particles as a seed of crystallization in an initial stage of the process.
[73] The amount of hematite seed added may be in a range of 0.001 ~ 1 parts by weight, and preferably in a range of 0.005 ~0.2 parts by weight, with respect to 100 parts by weight of the iron(III) salt. When the amount of hematite seed added is less than 0.001 parts by weight with respect to 100 parts by weight of the iron(III) salt, effects on the aspect ratio and dispersion of hematite platelet are insignificant. On the other hand, when the amount of hematite seed added is greater than 1 part by weight with respect to 100 parts by weight of the iron(III) salt, hematite particles are too small to easily obtain hematite platelet having an effective aspect ratio.
[74] Operation S20, αmprising uniformly mixing the hematite precursor aqueous solution, may be performed by stirring the obtained hematite mixed solution at a rotating speed of 200 rpm or greater, or using one of a homogenizer, a ball miller, a static mixer, ultrasonic waves, and a microwave device, or using at least two of these devices in αmbination.
[75] Operation S30 may be performed using an autoclave device at a temperature in a range of 150~250°C for 2~240 hours. In general, the greater the concentration of alkali, the lower the reaction temperature that produces hematite platelet particles. When the reaction temperature is less than 15O0C, it is difficult to obtain hematite platelet particles. On the other hand, when the reaction temperature is greater than 25O0C, the hematite platelet particles can be obtained, but in order for stable operation of a hydrothermal treatment device and economically preparing hematite platelet, an appropriate upper limit temperature may be 25O0C.
[76] In operation S30, the intermediate product produced in operation S20 acts as a seed
of crystal, thereby producing hematite platelet (α-Fe 2O3) crystal in which K, Na, Li, or Ca is employed by hydrothermal reaction.
[77] In addition, after operation S30, the method of preparing a hematite platelet may further include filtering, washing and drying the hematite platelet particles (operation S40) in order to obtain hematite platelet particles having a desired size and thickness.
[78] The size of hematite platelet particles prepared may be in a range of l~100 μm, and preferably in a range of 5 ~ 80 μm. When the size of the particles is less than 1 μm, reflectance is decreased. On the other hand, when the size of the particles is greater than 100 μm, the hematite platelet particles are not suitable as a metallic pigment.
[79] In addition, the hematite platelet may have an aspect ratio of 20 or greater, and preferably an aspect ratio of 25 or greater. When the aspect ratio of the hematite platelet is less than 20, it is difficult to produce interference colors as an optical property and adhesiveness of particles is decreased, resulting in poor use thereof. An upper limit of the aspect ratio is not limited, but when the aspect ratio of the hematite platelet is greater than 100, strong particle gloss may be realized.
[80] A hematite platelet pigment with metallic gloss in which the synthesized hematite platelet is used as a base and metal oxide is coated on the base is manufactured to prepare, for example, a pearl pigment with strong metallic effect.
[81] The hematite platelet pigment may be prepared, for example, by suspending the hematite platelet obtained using the preparation method as described above in deionized water, adding an acid such as hydrochloric acid or sulfuric acid to the resultant and stirring, simultaneously adding a metal chloride solution and an aqueous alkali solution to the aqueous solution and refluxing the resultant to prepare a hematite platelet particle aqueous solution coated with a metal oxide hydrate layer, and filtering, washing, drying and sintering the hematite platelet particle aqueous solution.
[82] The metal oxide coated on the surface of the hematite platelet is a metal oxide typically coated on the surface of pigment and used to produce metallic gloss and interference colors in the field of preparing metallic pigments. The metal oxide is not particularly limited, and may be, in particular, SnO 2, TiO2, ZrO2, SiO2, Al2O3, MgO, or MnO2, or at least two of these materials. More preferably, it is desirable to form a multi-layer coating structure by using a variety of metal oxides. For example, such a multi-layer coating structure may include a coating layer formed of SiO 2, and a TiO2 coating layer formed on the surface of the SiO 2<x>ating layer. The advantages of such a multi-layer coating structure are an increase in covering power and obtainment of high-quality interference colors.
[83] Hereinafter, the present invention will be described in further detail with reference to the following examples. These examples are only for illustrative purposes and are not intended to limit the scope of the present invention.
[84] First, synthesis of hematite platelet will be described.
[85]
[86] Experimental Example 1
[87] Synthesis of hematite platelet according to a change in the amount of potassiun chloride (KCl) as an additive salt added to a precursor mixed solution
[88] A mixed solution of 10 g of iron chloride (FeCl3), 12 g of potassium hydroxide
(KOH) and 120 g of water was stirred to prepare a hematite platelet precursor mixed solution. Then, 0.1~0.4 g of potassium chloride and 30 g of potassiun hydroxide were further added to the hematite platelet precursor mixed solution as an additive salt to change the composition ratio. In this regard, the mixed solution was prepared by uniformly mixing at 200 rpm or greater by using an agitator. Then the mixture was put in a hydrothermal reactor and heated at 17O0C for 20 hours. After the hydrothermal reaction was terminated, the hydrothermal reactor was cooled down at room temperature. Then the reactor was washed using distilled water more than 3 times and dried at 6O0C for 1 day to obtain a final product.
[89] The obtained final product was monocrystalline hematite platelet (α-Fe 2O3). FIG. 2 is a scanning electron microscopic (SEM) image of a side surface of hematite platelet particle powders prepared in Experimental Example 1-4. Referring to FIG. 2, it can be seen that as a result of measurement of the side surface of the hematite platelet particle, a monocrystalline hematite platelet having an aspect ratio of 27 (ratio of particle size/ thickness= llμml 0.63/M) was prepared. FIG. 3A is a SEM image of the overall shape of the hematite platelet particles of FIG. 2, and FIG. 3B is an optical microscopic image of a top surface of the hematite platelet particles of Experimental Example 1-4 . Referring to FIGS. 3 A and 3B, the particles have hexahedron-like crystal shapes in the form of platelet and red purple-colored monocrystals. FIG. 4 illustrates particle size distribution of the hematite platelet of FIG. 2 measured using a particle size analyzer (Malvern Co.). The particle sizes D10, D50, and D90 were measured as 9 μm, 17 μm, and 25 μm, respectively. FIG. 5 illustrates X-ray diffraction analysis results of the hematite platelet powder of FIG. 2. As a result of the estimation of crystallization, it was confirmed that the product was hematite (α-Fe 2O3, JCPDS No. 86-0550).
[90]
[91] Experimental Example 2
[92] Change in synthesis temperature of hematite platelet
[93] A mixed solution of 10 g of iron chloride (FeCl3), 12 g of potassium hydroxide
(KOH) and 120 g of water was stirred to prepare a hematite platelet precursor mixed solution. Then, 0.3 g of potassiun chloride (KCl) and 30 g of potassiun hydroxide were further added to the hematite platelet precursor mixed solution as an additive salt to change the (imposition ratio. In this regard, the mixed solution was prepared by uniformly mixing at 200 rpm or greater by using an agitator. Then the mixture was put in a hydrothermal reactor and heated at 170~220°C for 20 hours. After the hy- drothermal reaction was terminated, the hydrothermal reactor was oooled down at room temperature. Then the reactor was washed using distilled water more than 3 times and dried at 6O0C for 1 day to obtain a final product.
[94] The obtained final product was monocrystalline hematite platelet (α-Fe 2O3). FIG. 6 is a SEM image of a side surface of the hematite platelet power prepared in Experimental Example 2-1. Referring to FIG. 6, as a result of measurement of the side surface, it can be seen that a monocrystalline hematite platelet having an aspect ratio of 25 (ratio of particle size/thickness= 20/M/ 0.8 JM) was prepared.
[95]
[96] Experimental Example 3
[97] Synthesis of hematite platelet according to a change in the amount of potassiun hydroxide (KOH) added to a precursor mixed solution
[98] A mixed solution of 10 g of iron chloride (FeCl3), 12 g of potassium hydroxide
(KOH) and 120 g of water was stirred to prepare a hematite platelet precursor mixed solution. Then, potassium hydroxide was further added to the hematite platelet precursor mixed solution by changing the amount thereof in a range of 6-60 g to change the (imposition ratio. In this regard, the mixed solution was prepared by uniformly mixing at 200 rpm or greater by using an agitator. Then the mixture was put in a hydrothermal reactor and heated at 17O0C for 20 hours. After the hydrothermal reaction was terminated, the hydrothermal reactor was oooled down at room temperature. Then the reactor was washed using distilled water more than 3 times and dried at 6O0C for 1 day to obtain a final product.
[99] The obtained final product was monocrystalline hematite platelet (α-Fe 2O3). FIG. 7 is a SEM image of a side surface of the hematite platelet particles prepared in Experimental Example 3. Referring to FIG. 7, it can be seen that a monocrystalline hematite platelet having an aspect ratio of 13 (ratio of particle size/thickness= 23/M/ 1.8/M) was prepared.
[100] From Experimental Example 3, it can be confirmed that as the amount of KOH increases, the size of hematite platelet particles is proportionally increased, and the aspect ratio is somewhat increased. Moreover, it was confirmed that the aspect ratio of the hematite platelet particles obtained without adding an additive salt was less than 20.
[101]
[102] Experimental Example 4
[103] A method of preparing hematite platelet by adding nanoparticle hematite seed
[104] Hematite platelet was prepared in the same manner as in Experimental Example 2.
[105] FIG. 8 is a transmission electron microsGopic (TEM) image of a nanoparticle hematite seed used in Experimental Example 4. FIG. 9 is a SEM image of hematite platelet particle powder prepared in the same manner as in Experimental Example 2, by adding the nanoparticle hematite seed of FIG. 8 in an amount of 0.01 parts by weight with respect to 100 parts by weight of iron(III) salt. Referring to FIG. 9, as a result of measurement of the side surface of the particles, it can be seen that a mono- crystalline hematite platelet having an aspect ratio of 17 (a ratio of particle size/ thickness= 10/M/ 0.6/M) was prepared.
[106]
[107]
[108]
[109]
[HO]
[111]
[112]
[113]
[114]
[115]
[116] Table 1
[Table 1] [Table ]
[117] * The size and thickness of hematite platelet particles are calculated as an average value of sizes and thicknesses of 20 particles in an electron microscopic image. [118]
[119] Then, by using the hematite platelets prepared in Experimental Examples 1-4 as a base, hematite platelet pigments were obtained by the following examples and the effects thereof were evaluated.
[120] [121] Example 1 [122] 100~150 g of the hematite platelet particles prepared in Experimental Example 1-1
was suspended in 2L of deionized water, and then the temperature of the mixture was raised to 70~80°C. Then, a 5% hydrochloric acid was added to the mixture to adjust the pH of the mixture to 2, and the mixture was stirred for 30 minutes. Then, a 40% solution of TiOCl2 and NaOH was added to the mixture to form a TiO(OH) 2 coating layer on the surface of the hematite platelet particles. As the amount of the solution of TiOCl2 and NaOH to be added was increased, interference colors of gold, red, purple, blue, and green were exhibited. When a desired interference color was obtained, the addition of the solution of TiOCl2 and NaOH was stopped, and then the resultant was stirred for 10 minutes or greater. Then the resultant was filtered, washed and dried, and then sintered at 8000C to form a titanium dioxide (TiO 2)layer having an anatase structure on the surface of the hematite platelet particles.
[123]
[124] Example 2
[125] 100~150 g of the hematite platelet particles prepared in Experimental Example 1-1 was suspended in 2L of deionized water, and then the temperature of the mixture was raised to 70~80°C. Then, a 5% hydrochloric acid was added to the mixture to adjust the pH of the mixture to 2, and the mixture was stirred for 30 minutes. Then, 60 ml of a 5% SnCl4-5H2O solution and a NaOH solution were simultaneously added to the mixture to form a TiO(OH)2 coating layer on the surface of the hematite platelet particles. As the amount of the solution of TiOCl 2 and NaOH to be added was increased, thereby increasing the thickness of the coating layer, interference colors of gold, red, purple, blue, and green were exhibited. When a desired interference color was obtained, the addition of the TiOCl2 and NaOH solution was stopped, and then the resultant was stirred for 10 minutes or greater. Then the resultant was filtered, washed and dried, and then sintered at 8000C to form a TiO2 layer having a rutile structure on the surface of the hematite platelet particles. FIG. 10 is a SEM image of the hematite platelet particles coated with the TiO 2 layer.
[126]
[127] Example 3
[128] 100~150 g of the hematite platelet particles prepared in Experimental Example 1-2 was suspended in 2L of deionized water, and then the temperature of the mixture was raised to 70~80°C. Then, a 5% hydrochloric acid was added to the mixture to adjust the pH of the mixture to 2, and the mixture was stirred for 30 minutes. Then, a 40% solution of TiOCl2 and NaOH was added to the mixture to form a TiO(OH) 2 coating layer on the surface of the hematite platelet particles. In this regard, the solution of
TiOCl2 and NaOH was added until gold color was exhibited. Then the mixture was stirred for 30 minutes or greater, and an aqueous NaOH solution was added to the mixture to adjust the pH of the mixture to 3. When a desired color, pearl gray, was exhibited, an iron(III) chloride solution was added to the mixture. Then the resultant was filtered, washed and dried, and then sintered at 9000C to form a layer formed of TiO2 and Fe2O3 on the surface of the hematite platelet particles.
[129]
[130] Example 4
[131] 100~150 g of the hematite platelet particles prepared in Experimental Example 1-2 was suspended in 2L of deionized water, and then the temperature of the mixture was raised to 70~80°C. Then, a 5% hydrochloric acid was added to the mixture to adjust the pH of the mixture to 3, and the mixture was stirred for 30 minutes. An aqueous NaOH solution was added to the mixture to continuously maintain the pH level, and then an iron(III) chloride solution was added to the mixture until a desired color, pearl gray, was exhibited. Then the resultant was filtered, washed and dried, and then sintered at 9000C to form a Fe2O3 layer on the surface of the hematite platelet particles.
[132] According to the present invention, hematite platelets having a particle size of
1~ 100/M, a particle thickness of 0.3~4/M and an aspect ratio of 20 or greater can be prepared.
[133]
[134] While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the following claims.
[135]
Industrial Applicability
[136] The present invention relates to a hematite platelet, and a hematite platelet pigment including the hematite platelet ,.
[137] Hematite platelet can be used as a rust inhibiting pigment for steel structures, paint for protecting woods, and a print ink for plywood. Also, hematite that has a small particle size and is transparent is used as a coloring pigment for metallic paints, for example, vehicles, by using its metallic gloss properties.
[138] In addition, hematite has ultraviolet-ray absorbing properties and covering properties with respect to skin (skin covering effect), and thus is used as a material for forming
films for packaging foods, colorants for medicine containers, and an extender for cosmetics.
Claims
[1] A method of preparing a hematite platelet, oomprising preparing a hematite precursor aqueous solution αmprising iron(III) salt; an aqueous alkali solution; and an additive αmprising at least one selected from the group consisting of potassium-based salts αmprising potassium phosphate, potassium sulfate, potassium chloride, potassium nitrate, potassium carbonate, potassium hydrogen carbonate, potassium bromide, and potassium fluoride, sodium-based salts having the same anion as that of the potassium-based salts, lithium-based salts, and calcium-based salts; uniformly mixing the hematite precursor aqueous solution to obtain an intermediate product αmprising Fe +3 and at least one of K+, Na+, Li+, and Ca+; and hydrothermally treating the hematite precursor aqueous solution.
[2] The method of claim 1, wherein the hydrothermally treating process is performed at a temperature in a range of 150~250°C for 2~240 hours.
[3] The method of claim 1, wherein the iron(III) salt αmprises at least one of FeCl 3,
Fe2(SO4)3, and Fe(NO3)3.
[4] The method of claim 1, wherein the aqueous alkali solution αmprises at least one selected from the group consisting of potassium hydroxide, sodium hydroxide, calcium hydroxide, and lithium hydroxide.
[5] The method of claim 1, wherein the hematite precursor aqueous solution has a pH of 11 or greater.
[6] The method of claim 1, further αmprising, after the hydrothermally treating process, filtering, washing and drying the hematite platelet particles.
[7] The method of claim 1, wherein the hematite precursor aqueous solution further αmprises a hematite seed, constituting hematite nanoparticles having a size of l~50 nm, in an amount of 0.001~l parts by weight with respect to 100 parts by weight of the iron(III) salt.
[8] A hematite platelet prepared using the method of claim 1, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 /M, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater.
[9] A hematite platelet prepared using the method of claim 2, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 /M, a particle thickness of 0.3~4 /M,
and an aspect ratio of 20 or greater. [10] A hematite platelet prepared using the method of claim 3, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 μm, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater. [11] A hematite platelet prepared using the method of claim 4, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 μm, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater. [12] A hematite platelet prepared using the method of claim 5, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 μm, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater. [13] A hematite platelet prepared using the method of claim 6, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 μm, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater. [14] A hematite platelet prepared using the method of claim 7, wherein the hematite platelet αmprises hematite (α-Fe 2O3) particles in which K, Na, Li, or Ca is employed, and has a particle size of l~100 μm, a particle thickness of 0.3~4 μm, and an aspect ratio of 20 or greater. [15] A hematite platelet pigment in which the hematite platelet of claim 8 is used as a base, and a metal oxide is αtated on the base. [16] The hematite platelet pigment of claim 15, wherein the metal oxide αmprises at least one selected from the group consisting of SnO 2, TiO2, ZrO2, SiO2, Al2O3,
MgO, and MnO2. [17] The hematite platelet pigment of claim 15, wherein the metal oxide is formed as a multi-layer structure αmprising at least two layers. [18] The hematite platelet pigment of claim 16, wherein the metal oxide is formed as a multi-layer structure αmprising at least two layers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080064324A KR101026361B1 (en) | 2008-07-03 | 2008-07-03 | Method of manufacturing hematite platelets, hematite platelets and hematite platelets pigment fabricated using thereof |
KR10-2008-0064324 | 2008-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010002059A1 true WO2010002059A1 (en) | 2010-01-07 |
Family
ID=41466129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2008/004561 WO2010002059A1 (en) | 2008-07-03 | 2008-08-06 | Method of preparing hematite platelet, hematite platelet prepared using the same, and hematite platelet pigment including the hematite platelet |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101026361B1 (en) |
WO (1) | WO2010002059A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104005015A (en) * | 2014-06-12 | 2014-08-27 | 哈尔滨工业大学 | Method for conducting in-situ growth of alpha-Fe2O3 nano arrays on surface of steel |
EP2714594A4 (en) * | 2011-06-03 | 2015-05-20 | Orbite Aluminae Inc | Methods for preparing hematite |
EP2734654A4 (en) * | 2011-07-18 | 2015-06-03 | Orbite Aluminae Inc | Methods for separating iron ions from aluminum ions |
US9260767B2 (en) | 2011-03-18 | 2016-02-16 | Orbite Technologies Inc. | Processes for recovering rare earth elements from aluminum-bearing materials |
US9290828B2 (en) | 2012-07-12 | 2016-03-22 | Orbite Technologies Inc. | Processes for preparing titanium oxide and various other products |
US9353425B2 (en) | 2012-09-26 | 2016-05-31 | Orbite Technologies Inc. | Processes for preparing alumina and magnesium chloride by HCl leaching of various materials |
US9382600B2 (en) | 2011-09-16 | 2016-07-05 | Orbite Technologies Inc. | Processes for preparing alumina and various other products |
US9410227B2 (en) | 2011-05-04 | 2016-08-09 | Orbite Technologies Inc. | Processes for recovering rare earth elements from various ores |
US9534274B2 (en) | 2012-11-14 | 2017-01-03 | Orbite Technologies Inc. | Methods for purifying aluminium ions |
US9556500B2 (en) | 2012-01-10 | 2017-01-31 | Orbite Technologies Inc. | Processes for treating red mud |
AT519585A1 (en) * | 2017-02-02 | 2018-08-15 | Constantia Teich Gmbh | Transparent paint |
US10563066B2 (en) * | 2014-09-11 | 2020-02-18 | Lanxess Deutschland Gmbh | Red iron-oxide pigments with improved colour values |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101526540B1 (en) * | 2013-10-28 | 2015-06-08 | 씨큐브 주식회사 | Method of manufacturing of iron oxide based black glazed pigments |
KR101562611B1 (en) * | 2014-12-18 | 2015-11-02 | (주)바이오제닉스 | Iron capsule for cosmetic and manufacturing method the same |
KR101701447B1 (en) * | 2015-08-13 | 2017-02-02 | 한국세라믹기술원 | Method for preparing plate-shaped magnetic iron oxide and plate-shaped magnetic iron oxide prepared by the same |
KR101966239B1 (en) | 2017-10-25 | 2019-04-08 | 한국기초과학지원연구원 | Rod-like Iron Oxide Particles and the Fabrication Method Thereof |
KR102384572B1 (en) * | 2019-11-28 | 2022-04-08 | 서강대학교산학협력단 | Method for selectively preparing iron oxide from mixed metal chlorides including iron |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0193427A (en) * | 1987-09-30 | 1989-04-12 | Toda Kogyo Corp | Production of lamellar hematite particle powder |
JPH03109217A (en) * | 1989-09-13 | 1991-05-09 | Basf Ag | Preparation of platelet-like iron oxide |
JPH0656429A (en) * | 1992-07-31 | 1994-03-01 | Toda Kogyo Corp | Production of plate-like iron oxide particulate powder |
KR20010089601A (en) * | 1999-01-19 | 2001-10-06 | 플레믹 크리스티안 | Multilayer nacreous pigment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3577576B2 (en) * | 1995-04-10 | 2004-10-13 | メルク株式会社 | Surface treatment agent, surface-treated flaky pigment and method for producing the same |
-
2008
- 2008-07-03 KR KR1020080064324A patent/KR101026361B1/en active IP Right Grant
- 2008-08-06 WO PCT/KR2008/004561 patent/WO2010002059A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0193427A (en) * | 1987-09-30 | 1989-04-12 | Toda Kogyo Corp | Production of lamellar hematite particle powder |
JPH03109217A (en) * | 1989-09-13 | 1991-05-09 | Basf Ag | Preparation of platelet-like iron oxide |
JPH0656429A (en) * | 1992-07-31 | 1994-03-01 | Toda Kogyo Corp | Production of plate-like iron oxide particulate powder |
KR20010089601A (en) * | 1999-01-19 | 2001-10-06 | 플레믹 크리스티안 | Multilayer nacreous pigment |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9945009B2 (en) | 2011-03-18 | 2018-04-17 | Orbite Technologies Inc. | Processes for recovering rare earth elements from aluminum-bearing materials |
US9260767B2 (en) | 2011-03-18 | 2016-02-16 | Orbite Technologies Inc. | Processes for recovering rare earth elements from aluminum-bearing materials |
US9410227B2 (en) | 2011-05-04 | 2016-08-09 | Orbite Technologies Inc. | Processes for recovering rare earth elements from various ores |
US9150428B2 (en) | 2011-06-03 | 2015-10-06 | Orbite Aluminae Inc. | Methods for separating iron ions from aluminum ions |
EP2714594A4 (en) * | 2011-06-03 | 2015-05-20 | Orbite Aluminae Inc | Methods for preparing hematite |
EP2734654A4 (en) * | 2011-07-18 | 2015-06-03 | Orbite Aluminae Inc | Methods for separating iron ions from aluminum ions |
US10174402B2 (en) | 2011-09-16 | 2019-01-08 | Orbite Technologies Inc. | Processes for preparing alumina and various other products |
US9382600B2 (en) | 2011-09-16 | 2016-07-05 | Orbite Technologies Inc. | Processes for preparing alumina and various other products |
US9556500B2 (en) | 2012-01-10 | 2017-01-31 | Orbite Technologies Inc. | Processes for treating red mud |
US9290828B2 (en) | 2012-07-12 | 2016-03-22 | Orbite Technologies Inc. | Processes for preparing titanium oxide and various other products |
US9353425B2 (en) | 2012-09-26 | 2016-05-31 | Orbite Technologies Inc. | Processes for preparing alumina and magnesium chloride by HCl leaching of various materials |
US9534274B2 (en) | 2012-11-14 | 2017-01-03 | Orbite Technologies Inc. | Methods for purifying aluminium ions |
CN104005015B (en) * | 2014-06-12 | 2016-03-02 | 哈尔滨工业大学 | A kind of method of steel surface growth in situ α-Fe2O3 nano-array |
CN104005015A (en) * | 2014-06-12 | 2014-08-27 | 哈尔滨工业大学 | Method for conducting in-situ growth of alpha-Fe2O3 nano arrays on surface of steel |
US10563066B2 (en) * | 2014-09-11 | 2020-02-18 | Lanxess Deutschland Gmbh | Red iron-oxide pigments with improved colour values |
AT519585A1 (en) * | 2017-02-02 | 2018-08-15 | Constantia Teich Gmbh | Transparent paint |
AT519585B1 (en) * | 2017-02-02 | 2021-05-15 | Constantia Teich Gmbh | Transparent varnish |
Also Published As
Publication number | Publication date |
---|---|
KR20100004252A (en) | 2010-01-13 |
KR101026361B1 (en) | 2011-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010002059A1 (en) | Method of preparing hematite platelet, hematite platelet prepared using the same, and hematite platelet pigment including the hematite platelet | |
JP5535637B2 (en) | Multi-layer pigment showing color transfer | |
Fouda et al. | Synthesis and characterization of nanosized Fe2O3 pigments | |
Khattab et al. | Synthesis of CoxMg1− xAl2O4 nanospinel pigments by microwave combustion method | |
JPWO2003016218A1 (en) | Method for producing layered titanic acid, flaky titanic acid, flaky titanium oxide and flaky titanic acid | |
WO2017068444A1 (en) | Method of synthesizing ceramic oxide nanoparticles having tailored properties | |
CN105542517A (en) | White and interference-color matte flaky cored pigment and preparation method thereof | |
JP6449903B2 (en) | Plate-like aluminum oxide and method for producing the same | |
CN107760063A (en) | One kind 1:Bismuth Huang hybrid pigment of 1 type silicate mineral doping and preparation method thereof | |
Fouda et al. | Characterization and evaluation of nano-sized α-Fe2O3 pigments synthesized using three different carboxylic acid | |
CN102924978A (en) | Magnetic Prussian blue pigment and preparation method thereof | |
Yuan et al. | Synthesis and characterization of novel nontoxic BiFe1− xAlxO3/mica-titania pigments with high NIR reflectance | |
US20060264551A1 (en) | Black iron-based particles, and black paint and rubber or resin composition using the same | |
Štengl et al. | Composite pigments based on surface coated kaolin and metakaolin | |
Zhang et al. | Preparation and characterization of colored aluminum pigments Al/SiO2/Fe2O3 with double-layer structure | |
KR101526540B1 (en) | Method of manufacturing of iron oxide based black glazed pigments | |
Bala et al. | Preparation and characteristics of calcium carbonate/silica nanoparticles with core-shell structure | |
CN108502910B (en) | Insoluble inorganic salt micro-nano material and preparation method and application thereof | |
KR101782861B1 (en) | Flaky aluminum oxide and method of producing thereof | |
JP4190174B2 (en) | High iris color titanium oxide and its manufacturing method | |
JP2006291156A (en) | Production method of pearlescent pigment having high brilliance and pearlescent pigment produced by the production method | |
JP4446133B2 (en) | Fine yellow composite hydrous iron oxide pigment, process for producing the same, paint and resin composition using the pigment | |
EP0691307B1 (en) | Pigmentary material | |
JP4271425B2 (en) | Yellow pigment | |
Lemos et al. | Synthesis and characterization of iron oxides and their application as inorganic pigments in white paint |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08793075 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08793075 Country of ref document: EP Kind code of ref document: A1 |